|
Originally published In Press as doi:10.1074/jbc.M203458200 on May 15, 2002
J. Biol. Chem., Vol. 277, Issue 30, 27014-27020, July 26, 2002
Overexpression of Apolipoprotein B in the Heart Impedes Cardiac
Triglyceride Accumulation and Development of Cardiac Dysfunction in
Diabetic Mice*
Lars B.
Nielsen §,
Emil D.
Bartels , and
Entela
Bollano¶
From the Department of Clinical Biochemistry,
Rigshospitalet, University of Copenhagen, Copenhagen DK-2100, Denmark
and the ¶ Department of Cardiology, Wallenberg Laboratory,
Sahlgrenska University Hospital, Goteborg S41345, Sweden
The heart secretes apolipoprotein B (apoB)
containing lipoproteins. Herein, we examined whether the overexpression
of a human apoB transgene in the heart affects triglyceride
accumulation and development of cardiac dysfunction in
streptozotocin-treated diabetic mice. Blood glucose, plasma free fatty
acids, and plasma triglycerides were similarly affected in diabetic
wild type mice and diabetic apoB transgenic mice as compared with
non-diabetic mice of the same genotype. After 12 weeks, heart
triglycerides were increased by 48% in diabetic wild type mice. These
mice displayed an increased expression of brain natriuretic
peptide and deterioration of heart function on echocardiography.
In diabetic apoB transgenic mice, heart triglyceride levels were
identical to those in non-diabetic wild type and apoB transgenic mice,
and brain natriuretic peptide expression as well as echocardiographic
indexes of heart function were only marginally affected or unaffected.
The findings suggest that triglyceride accumulation in the heart is
important for development of diabetic cardiomyopathy in mice, and that
lipoprotein formation by cardiomyocytes plays an integrated role in
cardiac lipid metabolism.
*
The study was supported by grants from The Danish National
Research Council and The Danish Heart Association.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Clinical
Biochemistry KB3011, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Tel.: 45-3545-3011; Fax:
45-3545-2524; E-mail: larsbo@rh.dk.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wang, L. Ebermann, A. Sterner-Kock, S. Wika, H.-P. Schultheiss, A. Dorner, and T. Walther
Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice
Exp Physiol,
February 1, 2009;
94(2):
220 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-G. Niu and R. D. Evans
Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference
Am J Physiol Endocrinol Metab,
November 1, 2008;
295(5):
E1106 - E1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Chess and W. C. Stanley
Role of diet and fuel overabundance in the development and progression of heart failure
Cardiovasc Res,
July 15, 2008;
79(2):
269 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Peterson, P. Herrero, J. McGill, K. B. Schechtman, Z. Kisrieva-Ware, D. Lesniak, and R. J. Gropler
Fatty Acids and Insulin Modulate Myocardial Substrate Metabolism in Humans With Type 1 Diabetes
Diabetes,
January 1, 2008;
57(1):
32 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Bang, S. Bro, E. D. Bartels, T. X. Pedersen, and L. B. Nielsen
Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice
Am J Physiol Renal Physiol,
October 1, 2007;
293(4):
F1325 - F1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boudina and E. D. Abel
Diabetic Cardiomyopathy Revisited
Circulation,
June 26, 2007;
115(25):
3213 - 3223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lamant, F. Smih, R. Harmancey, P. Philip-Couderc, A. Pathak, J. Roncalli, M. Galinier, X. Collet, P. Massabuau, J.-M. Senard, et al.
ApoO, a Novel Apolipoprotein, Is an Original Glycoprotein Up-regulated by Diabetes in Human Heart
J. Biol. Chem.,
November 24, 2006;
281(47):
36289 - 36302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1489 - H1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Wallace, S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos
Prevalence and Determinants of Troponin T Elevation in the General Population
Circulation,
April 25, 2006;
113(16):
1958 - 1965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak
Adiposity of the Heart*, Revisited
Ann Intern Med,
April 4, 2006;
144(7):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. Chiu, A. Kovacs, R. M. Blanton, X. Han, M. Courtois, C. J. Weinheimer, K. A. Yamada, S. Brunet, H. Xu, J. M. Nerbonne, et al.
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
Circ. Res.,
February 4, 2005;
96(2):
225 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Madsen, M. L. S. Lindegaard, C. B. Andersen, P. Damm, and L. B. Nielsen
Human Placenta Secretes Apolipoprotein B-100-containing Lipoproteins
J. Biol. Chem.,
December 31, 2004;
279(53):
55271 - 55276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bro, F. Moeller, C. B. Andersen, K. Olgaard, and L. B. Nielsen
Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E-Deficient Mice
J. Am. Soc. Nephrol.,
June 1, 2004;
15(6):
1495 - 1503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Davy and J. E. Hall
Obesity and hypertension: two epidemics or one?
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2004;
286(5):
R803 - R813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yokoyama, H. Yagyu, Y. Hu, T. Seo, K. Hirata, S. Homma, and I. J. Goldberg
Apolipoprotein B Production Reduces Lipotoxic Cardiomyopathy: STUDIES IN HEART-SPECIFIC LIPOPROTEIN LIPASE TRANSGENIC MOUSE
J. Biol. Chem.,
February 6, 2004;
279(6):
4204 - 4211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Christoffersen, E. Bollano, M. L. S. Lindegaard, E. D. Bartels, J. P. Goetze, C. B. Andersen, and L. B. Nielsen
Cardiac Lipid Accumulation Associated with Diastolic Dysfunction in Obese Mice
Endocrinology,
August 1, 2003;
144(8):
3483 - 3490.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|